"Implant Sciences Corp. (IMSC.PK): It could be time to start paying attention to the still-obscure Implant Sciences Corp. This company and its technology could be gearing up to start making a splash in the homeland security arena and a recent earnings announcement offered some insight into just how quick the growth could materialize if its lead products start catching on in the mainstream.
The company's Quantum Sniffer™ QS-B220 benchtop explosives and narcotics trace detector has been operationally deployed to various airports around the United States, Asia and South America since it was introduced earlier this year and is just the type of product that could potentially become a staple in airport security around the globe, once a large contract or two is landed.
While anticipating a ramp-up of QS-B220 sales, earlier-model explosive detectors continue to pick up steam in the law-enforcement arena, as a report from earlier this month demonstrates. A recent extension of the company's line of credit and its maturity might also be an indication that the company is predicting an imminent uptick in demand for its products and services.
Given the rapidly-growing homeland and airport security sectors around the globe, Implant Sciences could be positioning itself for rapid growth. Worth keeping an eye on after last week's earnings report and Friday's seven percent price spike."
mplant Sciences' Quantum Sniffer QS-B220 Bench-Top Explosives Trace Detector Achieves ASTM E2520 Certification
Standard Establishes Effectiveness of QS-B220 for Security Screeners and First Responders
WILMINGTON, MA--(Marketwire -02/06/12)- Implant Sciences Corporation (OTCQB: IMSC.PK - News) (Pinksheets: IMSC.PK - News), a high technology supplier of systems and sensors for homeland security markets, announced today that its Quantum Sniffer™ QS-B220 bench-top explosives trace detector has passed all tests of the ASTM E2520-07 "Standard Practice for Verifying Minimum Acceptable Performance of Trace Explosive Detectors." The test confirms that the QS-B220 performs to the required standards of performance in the detection of trace amounts of explosives including TNT, RDX, and PETN. The tests were conducted by Cambridge Polymer Group, an independent laboratory. ASTM International, formerly known as the American Society for Testing and Materials (ASTM), is a globally recognized leader in the development and delivery of international voluntary consensus standards.
"The QS-B220's validation through this test brings it another step closer to commercial adoption in the US. Non-TSA security screeners and first responders can now purchase and deploy our bench-top explosives and narcotics trace detector in complete confidence that it is an effective technology," stated Glenn D. Bolduc, President and CEO of Implant Sciences. "We are confident in the performance of our QS-B220 and anticipate that this is the first of many detection standards around the world to which it will be successfully certified."
The QS-B220 had been engineered to meet the needs of a wide range of security applications. It has recently received CE Certification and is being evaluated by security organizations around the world.
About the Quantum Sniffer™ QS-H150
The QS-H150 is a handheld explosives trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. The QS-H150 uses no radioactive materials and features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability.
About the Quantum Sniffer™ QS-B220
The QS-B220, introduced in May 2011, is a bench-top explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives, plus narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.
About Implant Sciences
Implant Sciences develops, manufactures, and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed innovative proprietary technologies used in its explosives and narcotics trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences products have been deployed in a wide range of security environments including airports, subways, railways, cargo facilities, nuclear power plants, police departments, military units, government buildings, and financial institutions. The QS-H150 and QS-B220 are Department of Homeland Security (DHS) Qualified Anti-Terrorism Technologies under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.
Implant Sciences' Quantum Sniffer QS-B220 Achieves CE Certification 21-Dec-11 07:01 am
Implant Sciences' Quantum Sniffer QS-B220 Achieves CE Certification
CE Mark Opens Door for Sales of the Benchtop Explosives and Narcotics Trace Detector in Europe and Beyond
WILMINGTON, MA--(Marketwire - Dec 21, 2011) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, announced today that its recently launched Quantum Sniffer™ QS-B220 benchtop explosives and narcotics trace detector has received CE certification. The CE testing process evaluates the safety and performance of products against the harmonized standards defined by the 27 member nations of the European Union (EU).
"Since nearly all customers in Europe require CE certification, this is a key to opening up the European market for our QS-B220. It will also support our efforts outside of the EU, as buyers in many nations look to CE certification as a guide for quality and safety in their own markets," stated Bruce Bower, Implant Sciences' Senior Vice President of Sales and Marketing.
"This is a significant milestone for Implant Sciences and for our QS-B220. Europe is a substantial market for us, where we have established distribution channels already selling our QS-H150 handheld portable explosives trace detector," stated Glenn D. Bolduc, President and CEO of Implant Sciences. "With CE certification, we can immediately leverage these distribution channels to offer our benchtop model. Meeting CE standards also satisfies several requirements mandated by the U.S. Transportation Security Administration."
The QS-B220 benchtop explosives and narcotics trace detector is well suited for a variety of security settings, including high-traffic airports and borders. The system is currently being evaluated by security organizations around the world.
Here is the address for the Yahoo Finance message board for Implant Sciences.
Yahoo will NOT correct the problem on Implant Science Corp. data page.
IMSC Investors conference update
The Quantum Sniffer was demonstrated during presentation by CTO.
Pipeline is now in excess of $100 Million.
$2 Billion market in 2013.
L3, Boeing among other Fortune 500 cos. have contacted IMSC to integrate IMSC's technology into their products.
TSL working side by side with IMSC. IMSC believes it will get TSA certification in the next 6 to 9 months which positions them for strong growth.
Use of products in nuclear plants, Beijing Olympics, subways, airports.
Terrorists getting smarter. PETN gets through X-Ray and metal detectors. Quantum Sniffer detects PETN.
Non-contact, non-radioactive solution by IMSC. Overcome lack of privacy and dignity by TSA. TSA doesn't have IMSC's equipment which would improve their job.
Will be part of an integrated system "Tunnel of Truth" including ETD, X-Ray and Metal Detection.
Air cargo market is huge.
TSA wants a non-contact solution.
QS unit retails at $30,000 and is 24/7. Dog sniffers cost exceeds $100,000 and can only work 2 hours per day.
No radioactive materials in IMSC products. All competitors have radioactivity.
Can detect narcotics with benchtop along with explosives. Recent field test in US and overseas for cargo detection. Demos at Met Life Stadium, prisons, police depts. recently.
Strong Board with stellar credentials.
Innovative technology. Will leverage IP with Fortune 500 cos. Sold into 27 countries.
Intend to get TSA certification shortly.
WILMINGTON, MA--(Marketwire -11/02/11)- Implant Sciences Corporation (OTCQB: IMSC.PK - News) (Pinksheets: IMSC.PK - News), a high technology supplier of systems and sensors for homeland security markets, today announced that its Quantum Sniffer™ QS-B220 benchtop explosives trace detector has been approved to partner with the developmental test and evaluation group of the Transportation Security Laboratory (TSL) in order to optimize the QS-B220 detection technology. TSL is a Department of Homeland Security Federal Laboratory within the DHS Science and Technology Directorate (S&T), located at the William J. Hughes Technical Center, Atlantic City International Airport, New Jersey.
Implant Sciences has signed a Cooperative Research and Development Agreement (CRADA) with DHS S&T TSL to officially begin its technology optimization.
DHS S&T/TSL's core mission is to enhance homeland security, including the research, development and validation of solutions to detect and mitigate the threat of improvised explosive devices (IEDs). DHS S&T establishes CRADAs as public-private partnerships designed to expeditiously mature and deploy security technologies and to prepare products to achieve Transportation Security Administration (TSA) certification/qualification. TSA certified products may be used at ports of entry across the U.S., including airports.
Implant Sciences' Vice President of Technology, Todd Silvestri stated, "The insight of the professionals at TSL will be invaluable in preparing the QS-B220 to meet TSA's expectations. TSL brings extensive experience and expertise to the table which will help us build a better product."
"We are proud to be able to work with S&T to optimize our technology. This is a great example of a private-public partnership that helps save money for taxpayers while improving security in the United States," concluded Implant Sciences' President and CEO, Glenn D. Bolduc.
About the Quantum Sniffer QS-B220
The QS-B220 Quantum Sniffer, introduced in May 2011, is a benchtop explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, or homemade explosives and narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability. The QS-B220 benchtop explosives and narcotics trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act).
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. The QS-H150 and QS-B220 are Department of Homeland Security (DHS) Qualified Anti-Terrorism Technologies under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.